Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.67 USD | +1.81% | -0.66% | -5.40% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.40% | 2.44B | |
+0.15% | 42.86B | |
+12.11% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.93% | 25.15B | |
-23.76% | 18.63B | |
+27.24% | 12.37B | |
-3.60% | 11.92B | |
+7.21% | 11.21B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise